<DOC>
	<DOC>NCT01161706</DOC>
	<brief_summary>The purpose of the investigators study is to investigate the impact of a commercial vegetable juice on dietary vegetable intake and select cardiovascular risk factors in a generally healthy population. The study was a 12 week study with 3 groups who received 0, 8 or 16 fluid ounces daily of vegetable juice, along with education on the DASH (Dietary Approaches to Stop Hypertension) diet. All participants came in for 3 study visits at 0, 6 and 12 weeks into the study.</brief_summary>
	<brief_title>Clinical Investigation on the Effects of a Vegetable Juice Treatment</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>***Inclusion Criteria*** Age 40 to 65 yrs Subject's body mass index is between 18.5 34.9 kg/m2 Subject is willing and able to comply with the study protocols Subject is willing to consume a vegetablebased beverage daily for three months ***Exclusion Criteria*** Physical signs of health impairment Uncontrolled diabetes or hypertension Pregnant or lactating Active tuberculosis or lung disease (i.e. COPD) Renal or Liver disease Heart Disease, which includes Cardiovascular events and Stroke Cushing's syndrome Exercise trained individuals History of psychiatric disorders i.e. schizophrenia or bipolar or depression treated with antidepressants within the last 1 year Anxiety medications Use of MAOI inhibitors within the last 1 year (e.g., phenelzine (Nardil), tranylcypromine (Parnate), etc.) Quality of life score of 21 or above Routine use of prescription drugs or overthe counter medications, which may potentially modulate the outcome of this study; including antibiotics, aspirin and aspirincontaining formulations, COX2 inhibitors, antihistamines, corticosteroids, erectile dysfunction drugs Asthma (can be worsened by mild to moderate food allergies) Indications of substance or alcohol abuse within the last 3 years The volunteer is undergoing nicotine cessation therapy Laboratory values outside the reference range if determined to be clinically significant by Dr. M. Eric Gershwin Individuals with known saltsensitive hypertension History of stage 1 high blood pressure defined as systolic &gt; 140 and diastolic &gt; 90, with or without use of HTN medications MultiVitamin use other than a OneADay essential Use of herbal or plantbased supplements; omega3 fatty acids, and fish oils and unwilling to discontinue use while participating in the study Allergies to vegetables</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>vegetable juice</keyword>
	<keyword>cardiovascular</keyword>
	<keyword>blood pressure</keyword>
</DOC>